DULOXETINE ZENTIVA 30 mg, gastro-resistant capsule 7 capsules
Active ingredients: Duloxetine hydrochloride, DULOXÉTINE
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Gastro-resistant capsule7 capsulesorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- DULOXETINE ZENTIVA 30 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 7 gélule(s)
- Marketing authorisation holder
- ZENTIVA (REPUBLIQUE TCHEQUE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67885003CIP73021817CIP133400930218174Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DULOXÉTINEgélule | 30 mg · une gélule | FT |
| CHLORHYDRATE DE DULOXÉTINEgélule | 33,68 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.